SecSonar.com

Bio-Techne Corporation (TECH)

Bio-Techne Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Bio-Techne Corporation (TECH) is a Biotechnology company based in US with a market capitalization of $8.1B. Revenue grew 5.2% year-over-year and the company generated $256.6M in free cash flow. This page tracks TECH's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3.1K employees · IPO Feb 9, 1989

Valuation

Valuation & price

$43.30 · as of May 17, 2026 · -39.3% vs 52w high

94.2

P/E ratio

Latest-FY diluted EPS

4.22

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$71.38$57.91$44.43Jul 25Dec 25Jul 26Jul 7, 25$51.54Jul 9, 25$52.59Jul 11, 25$54.14Jul 15, 25$51.42Jul 17, 25$53.29Jul 21, 25$50.27Jul 23, 25$55.31Jul 25, 25$58.78Jul 29, 25$57.87Jul 31, 25$54.73Aug 4, 25$54.88Aug 6, 25$49.87Aug 11, 25$50.15Aug 13, 25$54.71Aug 15, 25$53.60Aug 19, 25$54.87Aug 21, 25$54.00Aug 25, 25$56.71Aug 27, 25$56.22Aug 29, 25$54.63Sep 3, 25$53.34Sep 5, 25$54.41Sep 9, 25$54.20Sep 11, 25$53.21Sep 16, 25$51.78Sep 18, 25$52.99Sep 22, 25$53.04Sep 24, 25$51.22Sep 26, 25$51.85Sep 30, 25$55.63Oct 2, 25$62.09Oct 6, 25$61.92Oct 8, 25$60.56Oct 10, 25$58.66Oct 14, 25$59.27Oct 16, 25$61.60Oct 21, 25$63.46Oct 23, 25$66.06Oct 27, 25$64.25Oct 29, 25$62.02Oct 31, 25$62.57Nov 4, 25$61.10Nov 6, 25$58.18Nov 10, 25$57.46Nov 12, 25$61.40Nov 14, 25$59.38Nov 18, 25$58.15Nov 20, 25$58.73Nov 25, 25$65.85Nov 28, 25$64.51Dec 2, 25$62.95Dec 4, 25$63.54Dec 8, 25$60.29Dec 10, 25$60.83Dec 12, 25$58.51Dec 16, 25$57.44Dec 18, 25$57.10Dec 22, 25$58.96Dec 24, 25$59.19Dec 29, 25$59.24Jan 2, 26$59.65Jan 6, 26$65.28Jan 8, 26$64.58Jan 12, 26$66.56Jan 14, 26$68.40Jan 16, 26$68.67Jan 21, 26$71.38Jan 23, 26$68.16Jan 27, 26$68.23Jan 29, 26$63.98Feb 2, 26$65.25Feb 4, 26$68.67Feb 9, 26$65.48Feb 11, 26$63.45Feb 13, 26$59.93Feb 18, 26$59.33Feb 20, 26$57.52Feb 24, 26$57.60Feb 26, 26$57.92Mar 2, 26$57.82Mar 4, 26$57.85Mar 6, 26$53.89Mar 10, 26$52.82Mar 12, 26$51.47Mar 17, 26$51.06Mar 19, 26$51.59Mar 23, 26$52.00Mar 25, 26$52.69Mar 27, 26$50.95Mar 31, 26$52.26Apr 2, 26$53.13Apr 7, 26$53.83Apr 9, 26$55.57Apr 13, 26$57.53Apr 15, 26$58.49Apr 17, 26$59.23Apr 22, 26$58.58Apr 24, 26$54.19Apr 28, 26$53.51Apr 30, 26$55.32May 4, 26$54.74May 6, 26$47.41May 8, 26$48.36May 12, 26$47.42May 14, 26$44.74May 18, 26$44.43May 20, 26$46.70May 22, 26$48.21May 28, 26$50.84Jun 1, 26$50.79Jun 3, 26$50.85Jun 5, 26$51.99Jun 9, 26$54.41Jun 11, 26$54.02Jun 15, 26$56.17Jun 17, 26$55.00Jun 22, 26$55.61Jun 24, 26$58.88Jun 26, 26$71.00Jul 2, 26$70.83
$43.3052-week range$71.38
Loading valuation history…

Fundamentals

Key fundamentals

$8.1B

Market cap

5.2%

Revenue growth (YoY)

64.8%

Gross margin

$256.6M

Free cash flow (USD)

$281.9M

Net debt

-0.1%

Share dilution

3/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$499.0MFY 2017$563.0MFY 2018$643.0MFY 2019$714.0MFY 2020$738.7MFY 2021$931.0MFY 2022$1.1BFY 2023$1.1BFY 2024$1.2BFY 2025$1.2B
$499M$1.2B

Free cash flow by year

2016 → 2025

FY 2016$127.0MFY 2017$128.3MFY 2018$149.4MFY 2019$156.2MFY 2020$153.5MFY 2021$307.9MFY 2022$280.4MFY 2023$216.1MFY 2024$236.1MFY 2025$256.6M
$127M$256.6M

Gross margin by year

2021 → 2025

FY 202168.0%FY 202268.4%FY 202367.7%FY 202466.4%FY 202564.8%
68.0%64.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventMerger AgreementJun 25, 2026Filing
  • 8-K eventAcquisition AnnouncedJun 25, 2026Filing
  • Insider sellInsider Sell $320KHerr Amy E. · Director · $320.4KMay 12, 2026Filing
  • 8-K eventEarnings ReleaseMay 6, 2026Filing
  • Quarterly report10-Q FiledMay 6, 2026Filing

Questions

Frequently asked questions

What is Bio-Techne Corporation's market cap?

Bio-Techne Corporation (TECH) has a market capitalization of $8.1B.

What is TECH's P/E ratio?

TECH trades at a price-to-earnings ratio of 94.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is TECH's price-to-book (P/B) ratio?

TECH trades at 4.22 times book value per share.

Are insiders buying TECH stock?

SEC Form 4 filings show no open-market insider buys at Bio-Techne Corporation in the last 90 days (1 sell).

Same arena

Related companies in Biotechnology

HALO

Halozyme Therapeutics, Inc.

$8B

IBRX

ImmunityBio, Inc.

$7.9B

CORT

Corcept Therapeutics Incorporated

$7.5B

PRAX

Praxis Precision Medicines, Inc.

$7.2B

KRYS

Krystal Biotech, Inc.

$9.1B

ALKS

Alkermes plc

$7.1B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.